Oral Ghrelin Agonist in Healthy Subjects
NCT00377377
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
EP1572 (ghrelin agonist) oral and duodenal application
Sponsor
University Hospital, Basel, Switzerland